SONIDA SENIOR LIVING INC (SNDA) Fundamental Analysis & Valuation

NYSE:SNDA • US1404752032

36.64 USD
+0.38 (+1.05%)
At close: Mar 6, 2026
36.64 USD
0 (0%)
After Hours: 3/6/2026, 8:04:00 PM

This SNDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, SNDA scores 1 out of 10 in our fundamental rating. SNDA was compared to 101 industry peers in the Health Care Providers & Services industry. SNDA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, SNDA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. SNDA Profitability Analysis

1.1 Basic Checks

  • SNDA had negative earnings in the past year.
  • SNDA had a positive operating cash flow in the past year.
  • In the past 5 years SNDA reported 4 times negative net income.
  • In the past 5 years SNDA reported 4 times negative operating cash flow.
SNDA Yearly Net Income VS EBIT VS OCF VS FCFSNDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • SNDA's Return On Assets of -6.10% is on the low side compared to the rest of the industry. SNDA is outperformed by 69.31% of its industry peers.
  • With a Return On Equity value of -64.36%, SNDA is not doing good in the industry: 73.27% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.1%
ROE -64.36%
ROIC N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNDA Yearly ROA, ROE, ROICSNDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • SNDA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNDA Yearly Profit, Operating, Gross MarginsSNDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

0

2. SNDA Health Analysis

2.1 Basic Checks

  • SNDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SNDA has been increased compared to 1 year ago.
  • Compared to 5 years ago, SNDA has more shares outstanding
  • Compared to 1 year ago, SNDA has an improved debt to assets ratio.
SNDA Yearly Shares OutstandingSNDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SNDA Yearly Total Debt VS Total AssetsSNDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 0.11, we must say that SNDA is in the distress zone and has some risk of bankruptcy.
  • SNDA has a Altman-Z score of 0.11. This is in the lower half of the industry: SNDA underperforms 76.24% of its industry peers.
  • SNDA has a Debt/Equity ratio of 8.19. This is a high value indicating a heavy dependency on external financing.
  • SNDA's Debt to Equity ratio of 8.19 is on the low side compared to the rest of the industry. SNDA is outperformed by 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.19
Debt/FCF N/A
Altman-Z 0.11
ROIC/WACCN/A
WACC7.88%
SNDA Yearly LT Debt VS Equity VS FCFSNDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

  • SNDA has a Current Ratio of 0.70. This is a bad value and indicates that SNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SNDA's Current ratio of 0.70 is on the low side compared to the rest of the industry. SNDA is outperformed by 85.15% of its industry peers.
  • A Quick Ratio of 0.70 indicates that SNDA may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.70, SNDA is not doing good in the industry: 80.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
SNDA Yearly Current Assets VS Current LiabilitesSNDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. SNDA Growth Analysis

3.1 Past

  • SNDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.13%, which is quite impressive.
  • Looking at the last year, SNDA shows a quite strong growth in Revenue. The Revenue has grown by 8.64% in the last year.
  • SNDA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.41% yearly.
EPS 1Y (TTM)42.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.65%
Revenue 1Y (TTM)8.64%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%14.7%

3.2 Future

  • SNDA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.29% yearly.
  • SNDA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.55% yearly.
EPS Next Y-26.32%
EPS Next 2Y-10.73%
EPS Next 3Y16.29%
EPS Next 5YN/A
Revenue Next Year28.76%
Revenue Next 2Y16.18%
Revenue Next 3Y12.55%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNDA Yearly Revenue VS EstimatesSNDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
SNDA Yearly EPS VS EstimatesSNDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

1

4. SNDA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SNDA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNDA Price Earnings VS Forward Price EarningsSNDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

  • SNDA's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.49
SNDA Per share dataSNDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • SNDA's earnings are expected to grow with 16.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.73%
EPS Next 3Y16.29%

0

5. SNDA Dividend Analysis

5.1 Amount

  • No dividends for SNDA!.
Industry RankSector Rank
Dividend Yield 0%

SNDA Fundamentals: All Metrics, Ratios and Statistics

SONIDA SENIOR LIVING INC

NYSE:SNDA (3/6/2026, 8:04:00 PM)

After market: 36.64 0 (0%)

36.64

+0.38 (+1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-10
Earnings (Next)04-01
Inst Owners81.64%
Inst Owner Change5.92%
Ins Owners18.97%
Ins Owner Change-0.04%
Market Cap687.73M
Revenue(TTM)375.42M
Net Income(TTM)-52.14M
Analysts45.71
Price Target32.13 (-12.31%)
Short Float %1.87%
Short Ratio5.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-10.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.98%
Min EPS beat(2)-69.93%
Max EPS beat(2)79.89%
EPS beat(4)3
Avg EPS beat(4)15.71%
Min EPS beat(4)-69.93%
Max EPS beat(4)79.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)21.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-53.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.83
P/FCF N/A
P/OCF 31.8
P/B 8.49
P/tB 11.74
EV/EBITDA 33.49
EPS(TTM)-2.72
EYN/A
EPS(NY)-3.7
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)1.15
OCFY3.14%
SpS20
BVpS4.32
TBVpS3.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.1%
ROE -64.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 8.19
Debt/FCF N/A
Debt/EBITDA 16.48
Cap/Depr 57.18%
Cap/Sales 8.42%
Interest Coverage N/A
Cash Conversion 53.73%
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 0.11
F-Score3
WACC7.88%
ROIC/WACCN/A
Cap/Depr(3y)55.33%
Cap/Depr(5y)43.9%
Cap/Sales(3y)8.53%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.65%
EPS Next Y-26.32%
EPS Next 2Y-10.73%
EPS Next 3Y16.29%
EPS Next 5YN/A
Revenue 1Y (TTM)8.64%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%14.7%
Revenue Next Year28.76%
Revenue Next 2Y16.18%
Revenue Next 3Y12.55%
Revenue Next 5YN/A
EBIT growth 1Y-18.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year698.64%
EBIT Next 3Y176.1%
EBIT Next 5YN/A
FCF growth 1Y34.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y318.97%
OCF growth 3YN/A
OCF growth 5YN/A

SONIDA SENIOR LIVING INC / SNDA FAQ

What is the fundamental rating for SNDA stock?

ChartMill assigns a fundamental rating of 1 / 10 to SNDA.


Can you provide the valuation status for SONIDA SENIOR LIVING INC?

ChartMill assigns a valuation rating of 1 / 10 to SONIDA SENIOR LIVING INC (SNDA). This can be considered as Overvalued.


What is the profitability of SNDA stock?

SONIDA SENIOR LIVING INC (SNDA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for SONIDA SENIOR LIVING INC?

The Earnings per Share (EPS) of SONIDA SENIOR LIVING INC (SNDA) is expected to decline by -26.32% in the next year.


Can you provide the dividend sustainability for SNDA stock?

The dividend rating of SONIDA SENIOR LIVING INC (SNDA) is 0 / 10 and the dividend payout ratio is -10.81%.